Lantheus Holdings, Inc. (LNTH): Gross Profit
$941.95M
Year ended 2025-12-31
$936.02M
Trailing 12 months to 2026-06-30
+17.4%
3-year compound annual growth
+46.7%
5-year compound annual growth
+21.4%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $941.95M | -4.7% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $988.29M | +39.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $709.54M | +22.0% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $581.70M | +209.9% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $187.69M | +35.3% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $138.76M | -20.6% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $174.81M | 0.0% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $174.88M | +7.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $162.13M | +17.7% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $137.78M | +1.7% | 2019-02-20, From 2016-01-01 |
| 2015-12-31 | $135.52M | +8.0% | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | $125.52M | +62.3% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $77.36M | n/a | 2016-03-02, From 2013-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $941.95M | -4.7% |
| Neogen Corp (NEOG) | 2026-05-31 | $408.50M | -3.1% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $576.60M | -1.5% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $2.66B | +11.8% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $13.44M | +85.9% |
| Immucell Corp (ICCC) | 2025-12-31 | $11.45M | +44.1% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.92M | +8.0% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $7.54M | +28.2% |
| Biomerica Inc (BMRA) | 2026-05-31 | $362.0K | -27.3% |
Compare LNTH, NEOG, MYGN, IDXX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗